# Ne oldu?
The Lancet Neurology published the article “Finding more intracranial aneurysms that will never rupture” (Wang et al., 2026). The paper does not present original research data; instead, it reviews existing knowledge and outlines potential pathways to identify aneurysms with a negligible chance of rupture. The authors—Kaiwen Wang, Qian Zhang, Zheng Wen, Chengcheng Zhu, Xiaolin Chen, Shuo Wang, and Qingyuan Liu—argue that current clinical practice relies heavily on aneurysm size, location, and basic morphological features, which may lead to overtreatment.
# Ayrıntılar
The article summarises three broad categories of emerging approaches:
- Advanced imaging biomarkers – High‑resolution vessel wall MRI, 4‑D flow MRI, and PET tracers are discussed as ways to assess wall inflammation, hemodynamic stress, and structural integrity. The authors note that early pilot studies suggest these modalities can differentiate stable from unstable lesions, but sample sizes are small and thresholds are not yet validated.
- Computational modelling and AI – Machine‑learning algorithms trained on multimodal imaging and clinical data have shown promise in predicting rupture risk. Wang et al. caution that most models are retrospective, lack external validation, and may be biased by the datasets on which they were built.
- Longitudinal cohort data – The authors stress the importance of large, prospective registries that track aneurysm evolution over years. Such data could clarify the natural history of small, incidentally discovered aneurysms and help define a “low‑risk” phenotype.
The perspective does not provide new quantitative risk estimates; instead, it highlights gaps in evidence and calls for collaborative research networks to generate robust, generalisable data.
# Neden önemli?
Over‑diagnosis of unruptured intracranial aneurysms has grown with the widespread use of magnetic‑resonance angiography. Current guidelines often recommend intervention for aneurysms larger than 7 mm or located in high‑risk regions, yet many small lesions remain stable for decades. Unnecessary surgical or endovascular treatment carries risks of stroke, cognitive decline, and financial burden. By improving the ability to label aneurysms as “unlikely to rupture,” clinicians could spare patients from invasive procedures, reduce healthcare costs, and focus surveillance resources on truly high‑risk cases.
# Sırada ne var?
The authors outline several next steps:
- Standardised imaging protocols across centres to enable pooled analyses of vessel‑wall characteristics.
- Prospective validation of AI‑driven risk scores in diverse populations, with transparent reporting of performance metrics.
- Creation of multinational registries that capture baseline imaging, clinical variables, and long‑term outcomes.
- Guideline updates that incorporate emerging biomarkers once sufficient evidence accumulates.
Until these initiatives bear fruit, the article advises clinicians to continue using established risk factors while discussing the uncertainty of rupture risk with patients.
The article is peer‑reviewed but does not present original trial data; its conclusions are therefore hypothesis‑generating rather than definitive.